Close Menu

Difficulties Abound

As part of its Evidence Gap series, the New York Times has a backgrounder on the obstacles facing personalized medicine -- getting pharmaceutical companies to develop tests, insurance companies to cover the cost, and doctors to order the test. It also goes into the confusion of contradictory validation study results as well as from inconclusive test results, saying it is not always clear what should be done medically.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.